Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Remember the month long climb in anticipation of Approval of Nicosan? You ain't Seen Nothing Yet! What do morons think is going to happen with anticipation of a production facility that will serve 9-12 million patients? Get a Clue Bashers and cry babies. At least try to use a couple of your freaking brain cells.
Alright, that's my rant for the day.
Once we get financing we make a base to build on. Very simple IMO. Once we get consistent updates from the company about WT Hell is going on we slowly move up. Add in a slow growing revenue stream and we have a winner. Hopefully the company has listened to our cry for change. Just a matter of time!
GM All. Does not help that people are posting pps going to the basement. I'll be buying another 500k when this thing settles out. Whatever that means. lol
Lyteinvestor, We don't need to prove anything to you. Listen to yourself. Your the only one making an issue about the 7.5% royality fee. Longs Know this as a FACT. Get a grip and find it yourself. If you are a long, your not doing yourself any favors with your last few posts and people arn't going to do you any favors.
Dude, forget Germany, we make the market not Germany. Although my Xkem shares are going to buy a new BMW335.
It's in the SEC filing's sometime back.
Now why would you say something stupid like that going into close???? Hmm Why don't you spread some fear around moron.
A Screw IT!!! I'm selling all my shares buying a new scooter. lol
SBSH back with the 999...They keep coming and going, hmm
level 2 shows the MM's on the bid and ask side. 2 colums of 15 mm's on tdameritrade.
A PR on Tuesday 8/15 would not surprise me. The last PR bailed us out of a downward spiral. Short lived as it was. lol We're due IMO. Better load up flippers. lol
SBSH giving in!!! lol
Poker they do that every day. lol What's 666 signal? The return of satan and his crew, lol
SBSH with another 999. Level 2 pro's, another signal?
Skip, Yes, people talk alot. But when it comes put up or shut up they ignore. They would loose their life purpose, if they took him up on the offer. lol
I know your not calling anyone a liar. One thing I've learned, everyone tends to have some spin when repeating conversations. Human nature... bigD has been right more than wrong in the past.
I take it you don't like the humor.
I believe you BigD, this loan thing is what's got me scratching my head. Whats this 3 way talk coming from jabber? lmao Your talkin phone 3 way right.
Just click your heals a few times repeating, there's no place like home, there's no place like home. The year should pop into head.
jabber??? "bigd has offered to do a 3 way with anyone on this board" WTHell.....LMAO you going to join him? lol
Prediction, OK...I'm putting my Neck on the Chopping Block. We get a PR no latter than Aug 22. lol
For those that missed this. Pfrenz found this last night.
Summary
Expert Opinion on Investigational Drugs
August 2006, Vol. 15, No. 8, Pages 833-842
(doi:10.1517/13543784.15.8.833)
Investigational agents for sickle cell disease
Iheanyi Okpala
St Thomas’ Hospital, University of London, London SE1 7EH, UK. iheanyi.okpala@gstt.sthames.nhs.uk
Developments in the treatment of sickle cell disease (SCD) have not kept pace with advances in understanding the pathophysiology of this haemoglobinopathy. Drugs undergoing preclinical and clinical assessment for the therapy of these globin gene disorders are discussed in this article. Beginning with investigational agents for treatment of SCD as a whole, the discussion proceeds to drugs being developed for specific manifestations or iatrogenic complications. Despite being licensed in the USA, the prototype antisickling agent, hydroxycarbamide, has not attained worldwide clinical use because of concerns about long-term toxicity. The less toxic decitabine, which (as with hydroxycarbamide) increases fetal haemoglobin level, cannot be administered orally; therefore, the search continues for effective and safe antisickling drugs that can be taken orally. The naturally occurring benzaldehyde 5-hydroxymethyl-2-furfural has shown promising antisickling properties in vitro, and when administered to transgenic sickle mice. These effects are surpassed by the new synthetic pyridyl derivatives of benzaldehyde. Studies in humans with SCD are required to assess the clinical efficacy of these benzaldehydes. Niprisan, another antisickling agent with significant clinical efficacy and an attractive safety profile, is undergoing further development. The prospects of antiadhesion therapy in SCD are demonstrated by a recombinant protein containing the Fc fragment of IgG fused to the natural ligand for selectins: the conjugate significantly inhibited blood vessel occlusion in transgenic sickle mice. Whereas the orally administrable iron-chelating agent deferasirox is likely to increasingly take the place of desferioxamine (which can only be given parenterally), effective treatment of priapism in SCD remains a distressing challenge.
Full Text PDF (14,126 KB) PDF Plus (415 KB)
I've only read 1/4 the posts today and it sounds like a day care center. Maybe someone will have smacked some sense into some of you by the time I get to the end? Hope so... lol
"We have significantly expanded our operations in Nigeria over the past year"
Let's read that again!
"We have significantly expanded our operations in Nigeria over the past year"
This is why we invested in this company right! So quit your Freaking Whining and Crying people. All you doing is Feeding Fear and playing into the hands those who want to buy at a lower pps. Sellers are the only losers at this pps. So guess what, Don't Sell. It' pretty freaking easy, Don't Sell. If you've done your DD, it's a No Brain-er.
OK, Well that's 4 from Indy so far. Glad to have you aboard.
Sparks I'm a little slow....IVHT interesting company.
Indpls, I saw your post, Camby right.
ot I just finished a big bowl of chocolate ice cream. want some??? lol alright...I'm starting to make myself sick.
LMAO no, it didn't the last time I checked. Although I think I lost my plastic wrap. can't find it. maybe madmax barrowed it? hmmm some food for thought. lol
OK, yep, a small world. Looks like we have the making of a midwest crew forming here. Would be good if all are long and strong. Time will tell. lol
Me Too!!! My boat is almost full. don't want to tip over.
I see you posted it!! sorry.
Summary
Expert Opinion on Investigational Drugs
August 2006, Vol. 15, No. 8, Pages 833-842
(doi:10.1517/13543784.15.8.833)
Investigational agents for sickle cell disease
Iheanyi Okpala
St Thomas’ Hospital, University of London, London SE1 7EH, UK. iheanyi.okpala@gstt.sthames.nhs.uk
Developments in the treatment of sickle cell disease (SCD) have not kept pace with advances in understanding the pathophysiology of this haemoglobinopathy. Drugs undergoing preclinical and clinical assessment for the therapy of these globin gene disorders are discussed in this article. Beginning with investigational agents for treatment of SCD as a whole, the discussion proceeds to drugs being developed for specific manifestations or iatrogenic complications. Despite being licensed in the USA, the prototype antisickling agent, hydroxycarbamide, has not attained worldwide clinical use because of concerns about long-term toxicity. The less toxic decitabine, which (as with hydroxycarbamide) increases fetal haemoglobin level, cannot be administered orally; therefore, the search continues for effective and safe antisickling drugs that can be taken orally. The naturally occurring benzaldehyde 5-hydroxymethyl-2-furfural has shown promising antisickling properties in vitro, and when administered to transgenic sickle mice. These effects are surpassed by the new synthetic pyridyl derivatives of benzaldehyde. Studies in humans with SCD are required to assess the clinical efficacy of these benzaldehydes. Niprisan, another antisickling agent with significant clinical efficacy and an attractive safety profile, is undergoing further development. The prospects of antiadhesion therapy in SCD are demonstrated by a recombinant protein containing the Fc fragment of IgG fused to the natural ligand for selectins: the conjugate significantly inhibited blood vessel occlusion in transgenic sickle mice. Whereas the orally administrable iron-chelating agent deferasirox is likely to increasingly take the place of desferioxamine (which can only be given parenterally), effective treatment of priapism in SCD remains a distressing challenge.
Full Text PDF (14,126 KB) PDF Plus (415 KB)
pfrenz is this what your refering to? Good Find! Sorry you didn't get your .025 shares. lol hope we never see it again.
St Thomas’ Hospital, University of London, London SE1 7EH, UK. iheanyi.okpala@gstt.sthames.nhs.uk
Developments in the treatment of sickle cell disease (SCD) have not kept pace with advances in understanding the pathophysiology of this haemoglobinopathy. Drugs undergoing preclinical and clinical assessment for the therapy of these globin gene disorders are discussed in this article. Beginning with investigational agents for treatment of SCD as a whole, the discussion proceeds to drugs being developed for specific manifestations or iatrogenic complications. Despite being licensed in the USA, the prototype antisickling agent, hydroxycarbamide, has not attained worldwide clinical use because of concerns about long-term toxicity. The less toxic decitabine, which (as with hydroxycarbamide) increases fetal haemoglobin level, cannot be administered orally; therefore, the search continues for effective and safe antisickling drugs that can be taken orally. The naturally occurring benzaldehyde 5-hydroxymethyl-2-furfural has shown promising antisickling properties in vitro, and when administered to transgenic sickle mice. These effects are surpassed by the new synthetic pyridyl derivatives of benzaldehyde. Studies in humans with SCD are required to assess the clinical efficacy of these benzaldehydes. Niprisan, another antisickling agent with significant clinical efficacy and an attractive safety profile, is undergoing further development. The prospects of antiadhesion therapy in SCD are demonstrated by a recombinant protein containing the Fc fragment of IgG fused to the natural ligand for selectins: the conjugate significantly inhibited blood vessel occlusion in transgenic sickle mice. Whereas the orally administrable iron-chelating agent deferasirox is likely to increasingly take the place of desferioxamine (which can only be given parenterally), effective treatment of priapism in SCD remains a distressing challenge.
ot backdoorbear The Bear Suck! J/k I was a Bear fan as a kid. My cousins now X husband played for Pittsburg and was cut after 3 years back in the 60s. He tried out for the Bears, they cut him for being an aszzhoe. lol
I'm a Colts fan that pukes a lot of beer ever time they choke. lol
Ahhh I see pfrenz, madmax or stevo is minding the store. lol
larry, did you enter the address for Xechem in Nigeria? Steve told us construction of the new larger facility was under way. They have already started producing in the smaller facility. tic toc tic toc Koboom$m$m$m
This is another reason I will Xechem to Succeed Spectacularly. As American citizens, we pay the Highest Price for drugs and medical treatments in the world. Yes, we have a very high quality of care. Still, few would disagree, The System is Broken.
http://news.yahoo.com/s/ap/20060812/ap_on_he_me/spending_to_death
OT scarecrow: Sorry to say at times, but I do live in Indy, never heard the news that another stupid young punk was shooting his pellet gun at cars outside of Chicago. So yes, I stand corrected/informed on that account.
I thought you were inferring that the suspect from the July 23, incident was still shooting at cars with a high powered rifle. Yes, it's all Bad, Crazy, Whacked and Insane. Although, I do find a measured difference between kids shooting a pellet gun at cars, and a Sick 17yr old with a rifle intentionally trying to cause harm.
My intention was to set the record straight as far as the suspect from the July 23, incident being apprehended. Not "prove you wrong". My foot never came close to my mouth.
"Authorities investigating the damaged vehicles have not found slugs or shell casings, but Dominguez said officials believe the damage was caused by some sort of firearm or pellet gun."
scarecrow, Your below statement is very reveling in terms of a rational thought process. Seems to me with your many posts calling for only "facts" and "truth" in regards to Xkem, you would require the same standard for yourself. The facts are in the link below.
http://www.indystar.com/apps/pbcs.dll/article?AID=/20060726/NEWS01/607260436
"penny be careful driving in ind. with all those whacko's shotting at cars...."
jabberstox Check out the link at the bottom of the page.
http://www.investorshub.com/boards/board.asp?board_id=6401
http://www.ultimateuploads.com/audio/view.php?play=4df42849f3e12a9379065276bbea8c3d